Otsubo et al. used next-generation sequencing and demonstrated that ERBB3 was more frequently altered in the somatic cells of fibrotic lung tissue from patients with IPF-associated lung cancer, which indicates that genetic variants of ERBB3 potentially contribute to IPF development [97]. This evidence concerns the gene ERBB3 and lung carcinoma.